nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—Localised oedema—Lamivudine—hepatitis B	0.0541	0.194	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.0415	0.0576	CbGpPWpGaD
Tazarotene—Sensitisation—Lamivudine—hepatitis B	0.0382	0.137	CcSEcCtD
Tazarotene—RARB—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.0373	0.0516	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors—HNF4A—hepatitis B	0.0364	0.0505	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.0357	0.0495	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.0357	0.0495	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—HNF4A—hepatitis B	0.0327	0.0453	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—HNF4A—hepatitis B	0.0313	0.0434	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—HNF4A—hepatitis B	0.0313	0.0434	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.0288	0.0399	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.0258	0.0358	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.0248	0.0343	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.0248	0.0343	CbGpPWpGaD
Tazarotene—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.0238	0.0855	CcSEcCtD
Tazarotene—Blood triglycerides increased—Lamivudine—hepatitis B	0.0208	0.0749	CcSEcCtD
Tazarotene—CYP2C8—CYP2E1 reactions—CYP2A6—hepatitis B	0.019	0.0263	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—MIF—hepatitis B	0.0175	0.0242	CbGpPWpGaD
Tazarotene—Acne—Lamivudine—hepatitis B	0.0162	0.0583	CcSEcCtD
Tazarotene—Oedema peripheral—Entecavir—hepatitis B	0.0146	0.0524	CcSEcCtD
Tazarotene—Inflammation—Lamivudine—hepatitis B	0.0141	0.0506	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.0122	0.0169	CbGpPWpGaD
Tazarotene—CYP2C8—Xenobiotics—CYP2A6—hepatitis B	0.0118	0.0163	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.0114	0.0158	CbGpPWpGaD
Tazarotene—CYP2C8—Tamoxifen metabolism—CYP2A6—hepatitis B	0.0113	0.0157	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.0109	0.0152	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.0105	0.0145	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.0105	0.0145	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.0102	0.0141	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.00979	0.0136	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.00979	0.0136	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.00898	0.0124	CbGpPWpGaD
Tazarotene—Discomfort—Telbivudine—hepatitis B	0.00891	0.032	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.00861	0.0119	CbGpPWpGaD
Tazarotene—Pain—Telbivudine—hepatitis B	0.0074	0.0266	CcSEcCtD
Tazarotene—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00727	0.0261	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—NR0B2—hepatitis B	0.00718	0.00994	CbGpPWpGaD
Tazarotene—Rash—Entecavir—hepatitis B	0.00664	0.0238	CcSEcCtD
Tazarotene—Dermatitis—Entecavir—hepatitis B	0.00663	0.0238	CcSEcCtD
Tazarotene—Rash—Adefovir Dipivoxil—hepatitis B	0.00648	0.0233	CcSEcCtD
Tazarotene—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00647	0.0232	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—NR0B2—hepatitis B	0.00644	0.00892	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—FAS—hepatitis B	0.00636	0.00882	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR0B2—hepatitis B	0.00617	0.00855	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NR0B2—hepatitis B	0.00617	0.00855	CbGpPWpGaD
Tazarotene—Pruritus—Telbivudine—hepatitis B	0.00612	0.022	CcSEcCtD
Tazarotene—Erythema—Lamivudine—hepatitis B	0.00597	0.0215	CcSEcCtD
Tazarotene—Rash—Telbivudine—hepatitis B	0.00545	0.0196	CcSEcCtD
Tazarotene—Dermatitis—Telbivudine—hepatitis B	0.00545	0.0196	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00506	0.00701	CbGpPWpGaD
Tazarotene—Discomfort—Lamivudine—hepatitis B	0.00502	0.018	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—HNF4A—hepatitis B	0.00497	0.00689	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00489	0.00677	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.00488	0.00676	CbGpPWpGaD
Tazarotene—Oedema—Lamivudine—hepatitis B	0.00487	0.0175	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00485	0.00672	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00482	0.00668	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.00468	0.00648	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—HNF4A—hepatitis B	0.00446	0.00618	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—GGT1—hepatitis B	0.00441	0.00612	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—HNF4A—hepatitis B	0.00428	0.00593	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—HNF4A—hepatitis B	0.00428	0.00593	CbGpPWpGaD
Tazarotene—Pain—Lamivudine—hepatitis B	0.00417	0.015	CcSEcCtD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00396	0.00549	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—CTNNB1—hepatitis B	0.00358	0.00496	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—AKR1B1—hepatitis B	0.00357	0.00495	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—CDKN1A—hepatitis B	0.0035	0.00485	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GGT2—hepatitis B	0.00347	0.00481	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR0B2—hepatitis B	0.00346	0.00479	CbGpPWpGaD
Tazarotene—Pruritus—Lamivudine—hepatitis B	0.00345	0.0124	CcSEcCtD
Tazarotene—RARB—Gene Expression—NR0B2—hepatitis B	0.0031	0.00429	CbGpPWpGaD
Tazarotene—Rash—Lamivudine—hepatitis B	0.00307	0.011	CcSEcCtD
Tazarotene—Dermatitis—Lamivudine—hepatitis B	0.00307	0.011	CcSEcCtD
Tazarotene—RXRB—Gene Expression—NR0B2—hepatitis B	0.00297	0.00412	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR0B2—hepatitis B	0.00297	0.00412	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TGFB1—hepatitis B	0.00289	0.00401	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.00274	0.0038	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—hepatitis B	0.0027	0.00374	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.00268	0.00372	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.00268	0.00371	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.00266	0.00369	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.00263	0.00365	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.00257	0.00356	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.00256	0.00355	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.00255	0.00354	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HNF4A—hepatitis B	0.00239	0.00332	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.00222	0.00307	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—hepatitis B	0.00218	0.00302	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HNF4A—hepatitis B	0.00215	0.00298	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.00213	0.00295	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	0.0021	0.00292	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.00207	0.00287	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HNF4A—hepatitis B	0.00206	0.00285	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HNF4A—hepatitis B	0.00206	0.00285	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.00199	0.00275	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.00183	0.00253	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.00175	0.00243	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GGT1—hepatitis B	0.00164	0.00228	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00139	0.00193	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000631	0.000874	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKR1B1—hepatitis B	0.00062	0.000859	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GGT2—hepatitis B	0.000594	0.000823	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2A6—hepatitis B	0.00036	0.000499	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000336	0.000465	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GOT2—hepatitis B	0.000326	0.000451	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GOT1—hepatitis B	0.000281	0.000389	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GGT1—hepatitis B	0.000281	0.000389	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000256	0.000355	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—hepatitis B	0.000149	0.000207	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTEN—hepatitis B	0.000114	0.000158	CbGpPWpGaD
